165 related articles for article (PubMed ID: 34277512)
41. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.
Sow PS; Otieno LF; Bissagnene E; Kityo C; Bennink R; Clevenbergh P; Wit FW; Waalberg E; Rinke de Wit TF; Lange JM;
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):262-7. PubMed ID: 17146376
[TBL] [Abstract][Full Text] [Related]
42. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
43. "I am not shy anymore": A qualitative study of the role of an interactive mHealth intervention on sexual health knowledge, attitudes, and behaviors of South African adolescents with perinatal HIV.
Bergam S; Sibaya T; Ndlela N; Kuzwayo M; Fomo M; Goldstein MH; Marconi VC; Haberer JE; Archary M; Zanoni BC
Reprod Health; 2022 Dec; 19(1):217. PubMed ID: 36457044
[TBL] [Abstract][Full Text] [Related]
44. Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
Brazier E; Tymejczyk O; Wools-Kaloustian K; Jiamsakul A; Torres MTL; Lee JS; Abuogi L; Khol V; Mejía Cordero F; Althoff KN; Law MG; Nash D;
PLoS Med; 2024 Mar; 21(3):e1004367. PubMed ID: 38498589
[TBL] [Abstract][Full Text] [Related]
45. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.
Adjé-Touré CA; Cheingsong R; Garcìa-Lerma JG; Eholié S; Borget MY; Bouchez JM; Otten RA; Maurice C; Sassan-Morokro M; Ekpini RE; Nolan M; Chorba T; Heneine W; Nkengasong JN
AIDS; 2003 Jul; 17 Suppl 3():S49-54. PubMed ID: 14565609
[TBL] [Abstract][Full Text] [Related]
46. Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda.
Izudi J; Alioni S; Kerukadho E; Ndungutse D
BMC Infect Dis; 2016 Oct; 16(1):614. PubMed ID: 27793124
[TBL] [Abstract][Full Text] [Related]
47. Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009.
Desmonde S; Coffie PA; Aka EA; Amani-Bosse C; Messou E; Dabis F; Ciaranello A; Leroy V
J Acquir Immune Defic Syndr; 2013 Jan; 62(1):e14-21. PubMed ID: 23262977
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
[TBL] [Abstract][Full Text] [Related]
49. CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients?
Anglaret X; Diagbouga S; Mortier E; Meda N; Vergé-Valette V; Sylla-Koko F; Cousens S; Laruche G; Ledru E; Bonard D; Dabis F; Van de Perre P
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(4):361-7. PubMed ID: 9111479
[TBL] [Abstract][Full Text] [Related]
50. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
[TBL] [Abstract][Full Text] [Related]
51. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.
Harambat J; Fassinou P; Becquet R; Touré P; Rouet F; Dabis F; Msellati P; Blanche S; Timité-Konan M; Salamon R; Leroy V;
BMC Public Health; 2008 May; 8():169. PubMed ID: 18492259
[TBL] [Abstract][Full Text] [Related]
52. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
54. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
Desmonde S; Avit D; Petit J; Amorissani Folquet M; Eboua FT; Amani Bosse C; Dainguy E; Mea V; Timite-Konan M; Ngbeché S; Ciaranello A; Leroy V
PLoS One; 2016; 11(12):e0166466. PubMed ID: 27935971
[TBL] [Abstract][Full Text] [Related]
55. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
Hailu GG; Wasihun AG
BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
[TBL] [Abstract][Full Text] [Related]
56. Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration.
Abo Y; Zannou Djimon M; Messou E; Balestre E; Kouakou M; Akakpo J; Ahouada C; de Rekeneire N; Dabis F; Lewden C; Minga A;
BMC Infect Dis; 2015 Apr; 15():176. PubMed ID: 25885859
[TBL] [Abstract][Full Text] [Related]
57. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
[TBL] [Abstract][Full Text] [Related]
58. HIV / AIDS country profile: Cote d'Ivoire. Risk analysis.
Da Camara-gomes F
AIDS Anal Afr; 1997 Apr; 7(2):12-4. PubMed ID: 12290341
[TBL] [Abstract][Full Text] [Related]
59. Childbearing desire and reproductive behaviors among women living with HIV: A cross-sectional study in Abidjan, Côte d'Ivoire.
Arikawa S; Dumazert P; Messou E; Burgos-Soto J; Tiendrebeogo T; Zahui A; Horo A; Minga A; Becquet R
PLoS One; 2020; 15(10):e0239859. PubMed ID: 33085671
[TBL] [Abstract][Full Text] [Related]
60. Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study.
Hermans LE; Carmona S; Nijhuis M; Tempelman HA; Richman DD; Moorhouse M; Grobbee DE; Venter WDF; Wensing AMJ
PLoS Med; 2020 Feb; 17(2):e1003037. PubMed ID: 32097428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
